To the Editor: As reported by Rowe and colleagues1 in their retrospective analysis of maternal immunisation, uptake of influenza and acellular pertussis vaccines among pregnant women remains unacceptably low. One contributing factor may be inconsistent messaging. Historically, vaccine manufacturers have included precautions about the lack of data on use in pregnancy in their product information sheets. Such precautions have been shown to lead to vaccination hesitancy and refusal among pregnant women.2,3 In contrast, the current edition of the Australian Immunisation Handbook states: “Pregnant women are routinely recommended to receive influenza vaccine … and pertussis‐containing vaccine”.4
The full article is accessible to AMA members and paid subscribers. Login to read more or purchase a subscription now.
Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.
- 1. Rowe SL, Perrett KP, Morey R, et al. Influenza and pertussis vaccination of women during pregnancy in Victoria, 2015–2017. Med J Aust 2019; 210: 454–462. https://www.mja.com.au/journal/2019/210/10/influenza-and-pertussis-vaccination-women-during-pregnancy-victoria-2015-2017
- 2. Top KA, Arkell C, Scott H, et al. Effect of package insert language on health‐care providers’ perceptions of influenza vaccination safety during pregnancy. Lancet Glob Health 2016; 4: e690–e691.
- 3. Brown E, Hotham E, Hotham N. Pregnancy and lactation advice: how does Australian Product Information compare with established information resources? Obstet Med 2016; 9: 130–134.
- 4. Australian Technical Advisory Group on Immunisation. The Australian Immunisation Handbook. Canberra: Australian Government, Department of Health and Ageing, 2018. https://immunisationhandbook.health.gov.au/ (viewed Nov 2019).
- 5. Advisory Committee on Vaccines. ACV meeting statement, meeting 8, 30 May 2018. Canberra: Therapeutic Goods Administration, 2018. https://www.tga.gov.au/committee-meeting-info/acv-meeting-statement-meeting-8-30-may-2018 (viewed Nov 2019).
No relevant disclosures.